Global EditionASIA 中文双语Français
Home / China / Health

WHO to assess Chinese COVID-19 vaccines soon: official

Xinhua | Updated: 2021-04-30 20:36
Share - WeChat
A nurse holds a syringe containing a coronavirus disease (COVID-19) vaccine made by the Beijing Institute of Biological Products, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), at a vaccination center during a visit, in Beijing, April 15, 2021. [Photo/Agencies]

GENEVA - The World Health Organization will meet between this week and next week to assess the Chinese COVID-19 vaccines developed by Sinopharm and Sinovac for the WHO Emergency Use Listing Procedure, according to a WHO official and recent media reports.

"We do have an advisory group meeting today, and it will meet the next days to assess Sinopharm," said Mariangela Batista Galvao Simao, WHO assistant director-general for access to medicines and health products, at a briefing on Monday.

"We will be assessing Sinovac" on May 5, she said, adding "we expect that for Sinopharm we will have a decision before the end of this week, and Sinovac most likely by the end of next week."

If approved, the Chinese vaccines would be the first from a non-western country to gain approval from the global health agency, said a Reuters report on Tuesday.

WHO backing of the Chinese vaccines could have a "significant impact" on their role in global vaccine supply, the South China Morning Post quoted Huang Yanzhong, a senior fellow for global health at the Council on Foreign Relations in New York, as saying.

"Authorising the emergency use of the Chinese vaccine would legitimise the international marketing of the Chinese vaccine and facilitate vaccination drives in countries that have received the vaccine," Huang said, adding that the WHO's approval will also allow the WHO-led COVAX initiative to buy Chinese vaccines for distribution.

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349